Collegium Pharmaceutical Inc (COLL)
R&D Expenses
$0.00
Quarterly · Period ending: · USD
COLL R&D Expenses
Latest reported$0.00period ending
Latest reported$0.00period ending
COLL Quarterly R&D Expenses ($3.27M → $0.00)
Quarterly R&D Expenses
High-resolution chart · PNG
COLL r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 3,983,000 | |
| 1,609,000 | |
| 1,450,000 | |
| 3,462,000 | |
| 2,930,000 | |
| 2,472,000 | |
| 2,141,000 | |
| 2,493,000 | |
| 2,666,000 | |
| 2,398,000 | |
| 2,491,000 | |
| 2,459,000 | |
| 2,992,000 | |
| 2,249,000 | |
| 1,907,000 | |
| 2,237,000 | |
| 2,268,000 | |
| 2,194,000 | |
| 2,069,000 | |
| 2,179,000 | |
| 2,130,000 | |
| 3,331,000 | |
| 3,254,000 | |
| 4,301,000 | |
| 4,062,000 | |
| 1,531,000 | |
| 3,358,000 | |
| 1,641,000 | |
| 1,445,000 | |
| 2,307,000 | |
| 5,818,000 | |
| 3,565,000 | |
| 3,269,000 |